PTGS2 and colitis: Blockade of PARP inhibits intercellular adhesion molecule 1 (ICAM-1) or cyclooxygenase-2 expression [13, 33], neutrophil recruitment [13, 14, 33], oxidant generation, and mucosal injury in murine colitis.